Diagnostic accuracy of two point-of-care kits for the diagnosis of Giardia species infection in dogs.

OBJECTIVES: The objective of this study was to compare results obtained by ZnSO4 Flotation and SNAP (®) Giardia to those generated by the new point-of-care tests Single and Triple Rapid. METHODS: Prospective study evaluating 51 canine faecal samples submitted at a reference laboratory for the presence of Giardia spp. Kappa statistics, specificity, sensitivity, positive predictive value (PPV) and negative predictive value (NPV) were calculated by comparing the new tests to the combined results of ZnSO4 and SNAP tests. RESULTS: There was fair (Single Rapid, j=0·434) to good (Triple Rapid, j =0·797) agreement with the reference tests. At this study's prevalence (59 to 61%), specificities and PPV were high (1·00) with both Rapid tests, but sensitivities and NPV were lower for the Single than for the Triple (0·48 vs 0·83 and 0·55 vs 0·80) tests. At lower prevalence rates, both tests exhibited a high PPV (1·00), but the NPV were higher with the Triple (0·96 to 0·99) than the Single (0·88 to 0·96) Rapid test. CLINICAL SIGNIFICANCE: Both tests exhibited excellent PPV values at all prevalence rates but an excellent NPV only at low prevalence. As the prevalence is likely to be low (<15%) in clinical settings, we propose that these tests may be helpful in the in-house diagnosis of Giardia spp infection. However, they exhibit lower sensitivity than the combined sensitivity of ZnSO4 and SNAP tests, particularly in high prevalence settings.

Measurement of thyroxine and cortisol in canine and feline blood samples using two immunoassay analysers.

OBJECTIVES: The AIA-360 (Tosoh Corporation) is an automated immunoassay analyser. The aims of this study were to estimate the precision of thyroxine and cortisol AIA-360 immunoassays in canine and feline samples and to compare the results produced with those obtained by a chemiluminescence analyser (Immulite® 1000, Siemens). METHODS: Blood samples from 240 clinical cases (60 dogs and 60 cats for both thyroxine and cortisol) were analysed using both instruments. RESULTS: Deming regression calculations showed excellent correlation (thyroxine, canine rs = 0 · 94, feline rs = 0 · 97; cortisol, canine rs = 0 · 97, feline rs = 0 · 97). Agreement between the two instruments was examined by Bland-Altman difference plots, which identified wide confidence intervals and outliers for thyroxine (canine n = 6, feline n = 4) and cortisol (canine n = 3, feline n = 4) results. Inter/intra-run precision of the AIA-360 was excellent for both cortisol and thyroxine (coefficients of variation <7%). CLINICAL SIGNIFICANCE: The instrument showed excellent correlation for cortisol and thyroxine in canine and feline samples demonstrating that the AIA-360 can be used in clinical practice. The agreement studies suggest that the results from the AIA-360 cannot be used interchangeably with those generated by the Immulite 1000 and should be interpreted using reference intervals that have been established specific to the AIA-360.

Measurement of prothrombin time and activated partial thromboplastin time in citrated whole blood samples from clinically ill dogs following storage.

OBJECTIVES: To assess the reliability of prothrombin time and activated partial thromboplastin time results generated from citrated whole blood samples following short-term storage at room temperature. METHODS: Clotting times were measured in blood samples from 40 dogs that showed a variety of clinical signs. Before measurement of prothrombin time and activated partial thromboplastin time in citrated plasma, whole blood samples were split in three aliquots; one was processed within 30 minutes of collection (fresh) while the remaining two were stored unseparated at room temperature for 24 (24RT) or 48 (48RT) hours. RESULTS: The median prothrombin time for the 24RT (7 seconds) and 48RT (7·2 seconds) samples were not significantly different to those obtained from the fresh (7·1 seconds) samples but the median activated partial thromboplastin time for the 24RT (12·6 seconds) and 48RT (12 seconds) samples were significantly shorter than those obtained from the fresh samples (14·2 seconds). CLINICAL SIGNIFICANCE: Storage of citrated whole blood at room temperature for 24 or 48 hours did not significantly alter the measurement of prothrombin time but resulted in significantly shorter activated partial thromboplastin time results. Extrapolating from these findings, it is proposed that unseparated clinical samples that are submitted to an external diagnostic laboratory for the performance of clotting times, may generate reliable prothrombin time but unreliable activated partial thromboplastin time results.

Biochemical assessment of canine body cavity effusions using three bench-top analysers.

OBJECTIVES: To assess the performance of three bench-top chemistry instruments for the analysis of canine effusions. Acceptable results were compared with those obtained by a reference chemistry analyser. METHODS: Total protein, albumin, creatinine and bilirubin concentrations were measured in 74 effusions using the VetScanVS2, VetTest8008 and SpotchemEZ analysers. Cholesterol and triglyceride concentrations were also measured by the VetTest and Spotchem. Results were analysed using Westgard's error analysis, Spearman's correlation, Bland-Altman plots and Deming regression. Results were considered acceptable when observed total error (TE(obs) ) was less than allowable total error (TE(A) ). RESULTS: VetScan error analysis revealed acceptable results for total protein (TE(obs) =1.11, TE(A) =4.7) and creatinine (TE(obs) =42.2, TE(A) =78.1). Correlation was fair for protein (r(s) =0.66) and creatinine (r(s) =0.76), but poor and not significant for bilirubin (r(s) =0.01, P=0.08), precluding error analysis. VetTest error analysis was acceptable for creatinine only (TE(obs) =5.55, TE(A) =25.5). Correlation was good (r(s) =0.81). The difference plot revealed a bias (95% confidence interval) of -1.5 (-37 to 40) and four outliers. The Spotchem did not generate a precise arithmetic value in most (56.9 to 73.6%) samples, precluding further analysis. CLINICAL SIGNIFICANCE: Acceptable results were obtained for total protein (VetScan) and creatinine [Vetscan, Vettest (with good correlation)]. The Spotchem is of limited value in canine effusion analysis.

Comparison of Measurements of 12 Analytes in Equine Blood Samples Using the In-Practice Falcor 350 and the Reference KoneLab 30i Analysers.

Falcor 350 is a wet-reagent biochemistry analyser that is available for in-house use. The aim of this study was to compare the results produced by this analyser with those obtained by the KoneLab 30i that served as the reference instrument. Blood samples from 60 clinical cases were analysed for urea, creatinine, total proteins, albumin, creatine kinase, aspartate aminotransferase, alkaline phosphatase, total bilirubin, total calcium, phosphate, sodium, and potassium using both instruments. Good to excellent correlations (r s value) value) were identified for creatinine (0.88), total proteins (0.92), albumin (0.93), creatine kinase (0.98), aspartate aminotransferase (0.98), alkaline phosphatase (0.94), total bilirubin (0.98), phosphate (0.95), and potassium (0.97). The correlations for total calcium (0.71), sodium (0.68), and urea (0.64) were fair. For albumin, aspartate aminotransferase, creatine kinase, phosphate, potassium, total bilirubin, creatinine, and total proteins, the two instruments produce values that are closely related to each other and are sufficiently similar to allow them to be used interchangeably without the need for additional correction factor computations. Because of differences in the methodologies, the Falcor results for alkaline phosphatase, total calcium, and sodium cannot be used interchangeably and should be interpreted using reference intervals established from the Falcor analyser.

Serum protein electrophoresis in 147 dogs.

Reference intervals for serum protein electrophoresis (SPE) were created from a group of 75 clinically healthy dogs and compared with SPE results obtained from clinical cases presented to the University of Bristol over an eight-and-a-half-year period. A total of 147 dogs, in which SPE had been performed, had complete case records available and thus met the inclusion criteria. Signalment and final diagnoses taken from the case records and SPE results were divided into normal and abnormal based on the newly established reference intervals. Cases were grouped according to the SPE protein fraction abnormalities and diagnosis using the DAMNITV classification system. Of the 147 cases, 140 (95.2 per cent) had abnormal SPE results. The most common protein fraction abnormality was decreased albumin (59.3 per cent) followed by a polyclonal increase in γ globulins (38.6 per cent). Decreased ß-1 globulins and increased ß-2 globulins were documented in 36.4 and 30.0 per cent of cases, respectively. The most common DAMNITV classification associated with abnormal SPE results was infectious/inflammatory disease, which was diagnosed in 79 of 140 cases (56.4 per cent). Monoclonal gammopathies were noted in eight dogs (5.7 per cent), and underlying lymphoproliferative disease was present in all cases where a diagnosis was achieved, including multiple myeloma (four dogs), splenic plasmacytoma (one dog), hepatic plasmacytoma (one dog) and lymphoma (one dog).

Effect of storage time on automated cell count and cytological interpretation of body cavity effusions.

The effect of 24- and 48-hour storage at room temperature on automated total nucleated cell count (TNCC), differential cell count (DCC) and cell morphology was assessed, and the effect of initial total protein concentration on canine and feline body cavity effusion samples (2 to 5 ml) was evaluated. At 24 and 48 hours, TNCC and absolute numbers of neutrophils, macrophages and small lymphocytes were significantly decreased and numbers of unrecognisable cells were significantly increased. Neoplastic cells and intracellular bacteria identified in fresh samples were missed at 24 and 48 hours. The initial total protein concentration was associated with an effect on percentage of unrecognisable cells and small lymphocytes over time. Change in TNCC over time would have resulted in misclassification of the effusion type in four of 47 samples.

Assessment of liver function in dogs using the 13C-galactose breath test.

The aim of this study was to evaluate the application of the 13C-galactose breath test (13C-GBT) in assessing canine liver function by applying it to a group of healthy dogs, and to a group with clinicopathological evidence of liver dysfunction. Breath samples were collected 30 min before ingestion of 13C-galactose, and then at regular intervals thereafter for 6 h. The proportion of 13CO2/12CO2 in the breath samples was measured by isotope-ratio mass spectrometry. There was no significant difference in recovery of 13CO2 in the diseased group, compared to the healthy controls, but there was considerable inter-subject variation in both groups, possibly due to differences in the rate of gastric emptying, which could preclude detection of alterations in hepatic metabolism of galactose. The results of this study do not support the application of the 13C-GBT for assessment of canine liver function.

Urinary protein:creatinine ratio in rabbits in relation to their serological status to Encephalitozoon cuniculi.

The concentrations of protein and creatinine were measured in urine samples from 74 healthy domestic pet rabbits, 54 of them seronegative to Encephalitozoon cuniculi and 20 seropositive. The calculated reference range for the urinary protein:creatinine ratio (UPC) of E cuniculi-seronegative rabbits was 0.11 to 0.40. There was no significant variation in the UPC due to the bodyweight, breed, sex, neutered status or husbandry of the rabbits. Seroconversion to E cuniculi was not found to be associated with clinical renal disease because none of the seropositive rabbits had azotaemia or proteinuria.

A retrospective study of canine D-dimer concentrations measured using an immunometric "Point-of-Care" test.

OBJECTIVES: To measure the D-dimer concentrations in both healthy dogs and dogs with and without evidence of thromboembolic disease/disseminated intravascular coagulation using a "Point-of-Care" test. METHODS: Sixty-seven clinical cases and 26 healthy dogs were included in this retrospective study. D-dimer was measured using the NycoCard D-dimer test. Clinical conditions were categorised based on clinical findings, laboratory results, imaging, cytology, histopathology, necropsy or a combination of these tests. RESULTS: There were no dogs for which the NycoCard D-dimer test did not produce a result. The D-dimer range in clinically healthy dogs was 0.1 to 0.5 mg/l (median 0.2 mg/l). In eight of nine cases with thromboembolic disease/disseminated intravascular coagulation and 43 of 58 of the cases without thromboembolic disease/disseminated intravascular coagulation , the D-dimer concentrations were greater than those of healthy dogs. CLINICAL SIGNIFICANCE: The NycoCard D-dimer test card required no specialised equipment and could therefore facilitate rapid screening for thromboembolic disease/disseminated intravascular coagulation in first opinion practice. Elevations in D-dimer concentration can be found in a number of clinical conditions apart from thromboembolic disease/disseminated intravascular coagulation and should not therefore be used as the sole basis of diagnosis. D-dimer may be considered a good screening test for thromboembolic disease/disseminated intravascular coagulation as only one case with histopathological evidence of thromboembolic disease/disseminated intravascular coagulation had a D-dimer concentration in the range seen in healthy dogs.

Comparison of measurements of 18 analytes in canine and feline blood samples using the in-practice Falcor 350 and the reference KoneLab 30i analysers.

OBJECTIVES: Falcor 350 (A. Menarini Diagnostics) is a wet-reagent biochemistry analyser that is available for in-house use. The aim of this study was to compare the results produced by this analyser with those obtained by a wet-reagent analyser (KoneLab 30i; Thermo Clinical Labsystems) that served as the reference instrument. METHODS: Blood samples from 120 clinical cases (60 dogs and 60 cats) were analysed for 18 analytes (urea, creatinine, total proteins, albumin, creatine kinase, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, total bilirubin, amylase, lipase, glucose, triacylglycerol, cholesterol, total calcium, phosphate, sodium and potassium) using both the reference and Falcor instruments. RESULTS: Good to excellent correlations (r(s) value) (canine/feline) were identified for urea (0.87/0.86), creatinine (0.96/0.99), total proteins (0.91/0.95), albumin (0.96/0.93), creatine kinase (0.98/0.99), aspartate aminotransferase (0.95/0.98), alanine aminotransferase (0.99/0.99), alkaline phosphatase (0.99/0.98), total bilirubin in dogs (0.88), amylase (0.99/0.87), lipase in dogs (0.88), glucose (0.97/0.98), triacylglycerol (0.93/0.97), cholesterol (0.99/0.99), total calcium (0.88/0.89), phosphate (0.94/0.97) and potassium (0.96/0.97). The correlations for sodium (0.41/0.61), total bilirubin in cats (0.78) and lipase in cats (0.25) were considered unacceptable. CLINICAL SIGNIFICANCE: For 13 of the 18 analytes (creatinine, total proteins, albumin, creatine kinase, aspartate aminotransferase, alanine aminotransferase, amylase, glucose, cholesterol, triacylglycerol, phosphate, potassium and urea) in both canine and feline samples, the two instruments produce values that are closely related to each other (excellent correlation) and are sufficiently similar to allow them to be used interchangeably without the need for additional correction factor computations (good agreement). Because of differences in the methodologies, the Falcor results for alkaline phosphatase, total calcium, sodium, lipase and total bilirubin cannot be used interchangeably with those generated by the KoneLab and should be interpreted using reference intervals established from the Falcor analyser.

Measurement of prothrombin time (PT) and activated partial thromboplastin time (APTT) on canine citrated plasma samples following different storage conditions.

Samples from 75 clinically ill dogs were utilised in the study. APTT and PT tests were performed immediately on fresh citrated plasma samples (Fresh). The remaining plasma was stored at -20 degrees C for less than 4 months (n=36 samples) or between 4 and 7 months (n=39 samples). In batches of five, frozen samples were thawed rapidly and APTT and PT tests were performed on the thawed samples immediately (0RT) and after storage at room temperature (23 degrees C, range: 22-25 degrees C) for 24h (24RT) and 48h (48RT). The median APTT value from the (0RT) samples was significantly longer than that obtained from fresh samples (15s vs. 13.2s) but the PT value was not statistically different (7.8s vs. 7.6s). The median APTT (15s) and PT (7.5s) results from the (24RT) samples were not statistically different to those from the (0RT) samples (APTT: 15s, PT: 7.6s) but both tests were significantly longer (APTT: 16.5s, PT: 9.2s) from the (48RT) samples. We concluded that long term batching and freezing of clinical samples at -20 degrees C is acceptable for measurement of PT but not of APTT. We demonstrated that APTT and PT results do not change following storage of samples at room temperature for 24h but storage for 48h may lead to statistically and clinically significant changes (values at least 25% higher than the high value of the laboratory's reference interval) in both clotting times.

Establishment of the European College of Veterinary Clinical Pathology (ECVCP) and the current status of veterinary clinical pathology in Europe.

After 5 years of development, the European College of Veterinary Clinical Pathology (ECVCP) was formally recognized and approved on July 4, 2007 by the European Board of Veterinary Specialisation (EBVS), the European regulatory body that oversees specialization in veterinary medicine and which has approved 23 colleges. The objectives, committees, basis for membership, constitution, bylaws, information brochure and certifying examination of the ECVCP have remained unchanged during this time except as directed by EBVS. The ECVCP declared full functionality based on the following criteria: 1) a critical mass of 65 members: 15 original diplomates approved by the EBVS to establish the ECVCP, 37 de facto diplomates, 7 diplomates certified by examination, and 5 elected honorary members; 2) the development and certification of training programs, laboratories, and qualified supervisors for residents; currently there are 18 resident training programs in Europe; 3) administration of 3 annual board-certifying examinations thus far, with an overall pass rate of 70%; 4) European consensus criteria for assessing the continuing education of specialists every 5 years; 5) organization of 8 annual scientific congresses and a joint journal (with the American Society for Veterinary Clinical Pathology) for communication of scientific research and information; the College also maintains a website, a joint listserv, and a newsletter; 6) collaboration in training and continuing education with relevant colleges in medicine and pathology; 7) development and strict adherence to a constitution and bylaws compliant with the EBVS; and 8) demonstration of compelling rationale, supporting data, and the support of members and other colleges for independence as a specialty college. Formal EBVS recognition of ECVCP as the regulatory body for the science and practice of veterinary clinical pathology in Europe will facilitate growth and development of the discipline and compliance of academic, commercial diagnostic, and industry laboratories in veterinary clinical pathology. Future needs are in developing sponsorship for resident positions, increasing employment opportunities, increasing compliance with laboratory, training, and continuing education standards, and advancing relevant science and technology.

Retrospective study of fever in dogs: laboratory testing, diagnoses and influence of prior treatment.

OBJECTIVES: To analyse the demographic information of dogs referred for investigation of fever, to determine the usefulness of various diagnostic investigations and to assess the effect of treatment before referral on the presence of fever at referral, the duration of the investigation and the ability to reach a final diagnosis. METHODS: The clinical records of 66 dogs, in which fever was part of the clinical signs documented by the referring veterinary surgeon, were reviewed. The effects of treatment 24 hours before referral on temperature at initial consultation and on time to diagnosis were evaluated. The effect of body temperature at initial consultation on cost and on time to diagnosis was also determined. The effect of insurance on costs incurred was assessed. The utility of different diagnostic investigations was recorded, and cases were classified according to the final diagnosis. RESULTS: Only 34.8 per cent of dogs were diagnosed with immune-mediated disease, with most frequent diagnoses being steroid-responsive meningitis and polyarthritis. Treatment 24 hours before referral significantly increased the time to diagnosis (P = 0.004) and affected the presence of fever at referral (P = 0.006). Insurance status did not significantly affect cost incurred by the owner. CLINICAL SIGNIFICANCE: This study documents a high incidence of immune-mediated disease in dogs referred for investigation of fever. It also documents a higher incidence of inflammatory central nervous system disease in febrile dogs than that reported previously. Of the diagnostic modalities employed in the majority of cases, radiography, cytology and bacteriological and fungal cultures (fluids/tissues) were the most useful. It is suggested that treatment is withdrawn or withheld before commencing diagnostic investigation of fever.

Concentrations of C-reactive protein in effusions in dogs.

The concentration of C-reactive protein (CRP) was measured in effusions from 50 dogs to assess the potential for measuring this protein to differentiate body cavity fluids. The effusions were classified as either transudates, modified transudates or exudates according to their total protein concentration, total nucleated cell count, cytological findings and aetiology, and the concentration of CRP was determined by a time-resolved immunofluorometric assay. There were significant differences between the concentrations of CRP in the three types of effusion; the highest concentrations were observed in the exudates (4.47 to 54.59 microg/ml), the lowest were in the transudates (0.0094 to 7.87 microg/ml), and the modified transudates contained intermediate concentrations of CRP (0.045 to 10.78 microg/ml). A cut-off value of 4 microg/ml had a sensitivity of 100 per cent and a specificity of 94.4 per cent for differentiating transudates from exudates, and a cut-off value of 11 microg/ml had a sensitivity of 88.2 per cent and a specificity of 100 per cent for distinguishing modified transudates from exudates. However, a cut-off value of 1 microg/ml had a lower sensitivity (80 per cent) and an unacceptably low specificity (66.7 per cent) for differentiating transudates from modified transudates.

Analysis of canine and feline blood samples using the Kuadro in-house wet-reagent chemistry analyser.

OBJECTIVES: Kuadro is a new wet-reagent biochemistry analyser that is available for in-house use. The aim of this study was to compare the results produced by this analyser with those obtained by a wet-reagent analyser (KoneLab 30i) that served as the reference instrument. METHODS: Blood samples from 80 clinical cases (40 dogs and 40 cats) were analysed for urea, creatinine, total proteins, albumin, glucose, cholesterol, alanine aminotransferase, alkaline phosphatase, total bilirubin, amylase, total calcium, and phosphate using both the reference and Kuadro instruments. RESULTS: Kuadro performed very well on canine and feline samples, showing clinically acceptable correlations (r value) (canine/feline) for urea (0.99/0.97), creatinine (0.99/0.98), total proteins (0.95/0.97), albumin (0.98/0.90), glucose (0.99/0.99), cholesterol (0.99/0.99), alanine aminotransferase (1.00/0.99), alkaline phosphatase (0.96/0.99), total bilirubin (1.00/1.00), amylase (0.98/0.96), and phosphate (0.91/0.92). The correlation for total calcium measurements was clinically unacceptable (0.78/0.83). CLINICAL SIGNIFICANCE: Urea, creatinine, albumin, glucose, cholesterol, alanine aminotransferase, and phosphate Kuadro values can be used interchangeably with those generated by the reference analyser. Alkaline phosphatase, amylase, and total proteins Kuadro values cannot be used interchangeably, as Kuadro overestimated alkaline phosphatase and amylase and underestimated total protein measurements. Kuadro significantly underestimated total calcium concentrations due to the shorter incubation time used by the Kuadro analyser compared with the incubation time used in the reference analyser assay system.

Analysis of canine and feline haemograms using the VetScan HMT analyser.

The VetScan HMT is an impedance counter haematology analyser which produces a full blood count and three-part white blood cell differential. The aim of this study was to compare the results generated by the analyser with those obtained by standard methods used routinely in the authors' laboratory. Blood samples from 68 dogs and 59 cats were run on the VetScan HMT analyser and also subjected to reference methods, and the results obtained were compared. Correlation coefficients (feline/canine) were: 0.97/0.99 for haematocrit (Hct), 0.98/0.99 for haemoglobin (Hb), 0.81/0.98 for total white blood cells (WBC), and 0.89/0.97 for granulocyte and 0.65/0.93 for platelet counts. Coefficients for lymphocyte counts were 0.25/0.28 and for monocyte counts were 0.12/0.79. In conclusion, the VetScan HMT performed well on canine samples, showing excellent correlation for canine Hct, Hb, RBC, WBC, granulocyte and platelet counts. For feline samples, although there was excellent correlation for Hct, Hb and RBC, the WBC and three-part white blood cell differential and platelet count should be interpreted with caution as they can be unreliable.

Determination of solid- and liquid-phase gastric emptying half times in cats by use of nuclear scintigraphy.

OBJECTIVE: To use nuclear scintigraphy to establish a range of gastric emptying half times (t1/2) following a liquid or solid meal in nonsedated cats. ANIMALS: 12 clinically normal 3-year-old domestic shorthair cats. PROCEDURE: A test meal of 75 g of scrambled eggs labeled with technetium Tc 99m tin colloid was fed to 10 of the cats, and solid-phase gastric emptying t1/2 were determined by use of nuclear scintigraphy. In a separate experiment, 8 of these cats plus an additional 2 cats were fed 18 ml (n = 5) or 36 ml (n = 5) of a nutrient liquid meal labeled with technetium Tc 99m pentetate. Liquid-phase gastric emptying t1/2 then were determined by use of scintigraphy. RESULTS: Solid-phase gastric emptying t1/2 were between 210 and 769 minutes (median, 330 minutes). Median liquid-phase gastric emptying t1/2 after ingestion of 18 or 36 ml of the test meal were 67 minutes (range, 60 to 96 minutes) and 117 minutes (range, 101 to 170 minutes), respectively. The median t1/2 determined for cats receiving 18 ml of the radiolabeled liquid was significantly less than that determined for cats receiving 36 ml of the test meal. CONCLUSIONS AND CLINICAL RELEVANCE: The protocol was tolerated by nonsedated cats. Solid-phase gastric emptying t1/2 were prolonged, compared with liquid-phase t1/2, and a major factor governing the emptying rate of liquids was the volume consumed. Nuclear scintigraphy may prove useful in assessing gastric motility disorders in cats.

Assessment of a breath collection technique and portable breath hydrogen monitor for use in cats and dogs.

Until now the use of breath hydrogen testing in companion animal gastroenterology has been limited to academic institutions because of the expense of the equipment. Recently portable breath hydrogen monitors, designed for use in paediatric gastroenterology, have been developed. They may be suitable for use in veterinary medicine as an ancillary diagnostic aid but, before widespread use can be recommended, thorough validation is required. Hydrogen breath tests were conducted in five dogs and four cats, undergoing investigations for small intestinal disease. Breath samples were taken using a closed-flow collection system and concurrently analysed with a commercially available portable breath hydrogen monitor and a previously validated breath hydrogen monitor. In cats, sample collection was troublesome and complete studies could only be performed in two individuals. Good correlation was demonstrated between the readings of both monitors (rs=0.902 and 0.935 for dogs and cats respectively; P<0.002) but agreement was poor with significant under-read from the portable monitor. Our results demonstrate that more studies on validation and the generation of a reference range would be required before the use of this portable hydrogen monitor could be recommended.

Use of the breath hydrogen test to assess the effect of age on orocecal transit time and carbohydrate assimilation in cats.

OBJECTIVE: To evaluate the effect of age on orocecal transit time (OCTT) in cats, using the breath hydrogen test, and to assess potential differences in nutrient absorption. ANIMALS: 27 healthy cats. PROCEDURE: Cats were allocated to the following 3 groups on the basis of age: group A (9 kittens, 5 to 7 months old), group B (9 young adults, 3 to 5 years old), and group C (9 older cats, 12 to 15 years old). Cats were fed a standard canned diet for 2 weeks prior to measurement of OCTT. Exhaled hydrogen concentration (parts per minute [ppm x min]) was monitored for 8 hours after feeding 60 g of the canned diet. RESULTS: Mean OCTT in group-A cats was 203 minutes (range, 90 to 345 minutes), which was significantly different from that in group-B (317 minutes; range, 180 to 435 minutes) and group-C (309 minutes; range, 225 to 375 minutes) cats. Median area under the breath hydrogen excretion time curve (ppm x min) for the 8-hour monitoring period, first 45 minutes, and 105 minutes after OCTT for the 3 groups was not significantly different among groups. CONCLUSIONS: Kittens had significantly faster OCTT than did adult cats.